Lexeo Therapeutics, Inc (LXEO) insider trading
Every open-market stock purchase and sale by Lexeo Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Louis Edward Tamayo (CFO) and 2 others sold $43.2K in the last 90 days.
- Last insider buy: Paula H Cholmondeley (Insider), $105K, 22 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $729K (18 sales). Last close $4.88 on Aug 21, 2026.
Recent LXEO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 24, 2026 | Jose Manuel Otero (COO) | Bought (not open market) | — |
| Sep 24, 2026 | Richard Nolan Townsend (CEO) | Bought (not open market) | — |
| Sep 24, 2026 | Louis Edward Tamayo (CFO) | Bought (not open market) | — |
| Sep 24, 2026 | Narinder Pal Bhalla (C-suite exec) | Bought (not open market) | — |
| Sep 14, 2026 | Narinder Pal Bhalla (C-suite exec) | Bought (not open market) | $9.7K |
| Sep 14, 2026 | Richard Nolan Townsend (CEO) | Bought (not open market) | $6.1K |
| Sep 14, 2026 | Jose Manuel Otero (COO) | Bought (not open market) | $5.6K |
| Aug 18, 2026 | Louis Edward Tamayo (CFO) | Sold | $20.2K |
| Aug 18, 2026 | Richard Nolan Townsend (CEO) | Sold | $16.6K |
| Aug 18, 2026 | Jose Manuel Otero (COO) | Sold | $6.5K |
| Jun 25, 2026 | Mette Kirstine Agger (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Brenda Cooperstone (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Reinaldo M Diaz (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Steven Altschuler (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Paula H Cholmondeley (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Timothy Van Hauwermeiren (Insider) | Bought (not open market) | — |
| Jun 25, 2026 | Tolga Tanguler (Insider) | Bought (not open market) | — |
| May 18, 2026 | Richard Nolan Townsend (CEO) | Sold | $16.9K |
| May 18, 2026 | Jose Manuel Otero (COO) | Sold | $6.6K |
| Apr 28, 2026 | Laura Sepp-Lorenzino (Insider) | Bought (not open market) | — |
| Apr 6, 2026 | Richard Nolan Townsend (CEO) | Sold | $313K |
| Mar 13, 2026 | Jose Manuel Otero (COO) | Bought (not open market) | $15.7K |
| Mar 13, 2026 | Richard Nolan Townsend (CEO) | Bought (not open market) | $6.9K |
| Feb 18, 2026 | Richard Nolan Townsend (CEO) | Sold | $64.9K |
| Feb 18, 2026 | Jose Manuel Otero (COO) | Sold | $19.3K |
Who's trading LXEO
- Narinder Pal Bhalla, C-suite exec: other filings, last Sep 24, 2026
- Richard Nolan Townsend, CEO: sold $539K (7 sales), last Sep 24, 2026
- Jose Manuel Otero, CTO: sold $58K (6 sales), last Sep 24, 2026
- Louis Edward Tamayo, CFO: sold $20.2K (1 sale), last Sep 24, 2026
- Brenda Cooperstone, Insider: other filings, last Jun 25, 2026
- Timothy Van Hauwermeiren, Insider: other filings, last Jun 25, 2026
- Tolga Tanguler, Insider: other filings, last Jun 25, 2026
- Reinaldo M Diaz, Insider: other filings, last Jun 25, 2026
- Mette Kirstine Agger, Insider: other filings, last Jun 25, 2026
- Steven Altschuler, Insider: other filings, last Jun 25, 2026
- Paula H Cholmondeley, Insider: other filings, last Jun 25, 2026
- Laura Sepp-Lorenzino, Insider: other filings, last Apr 28, 2026
- Eric Adler, C-suite exec: sold $35.9K (3 sales), last Nov 18, 2025
- Jenny Robertson, C-suite exec: sold $36.6K (3 sales), last Nov 18, 2025
- Tai Sandi See, C-suite exec: sold $38.3K (3 sales), last Nov 18, 2025
Get free alerts when an insider at Lexeo Therapeutics, Inc files a new trade →